Aslan Pharmaceuticals Ltd ADR
(ASLN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,396 | 21,252 | 40,818 | 40,944 | 57,497 |
| Receivables | N/A | N/A | N/A | 12,000 | N/A |
| Other current assets | 2,179 | 2,878 | 3,474 | 2,135 | 2,611 |
| TOTAL | $20,576 | $24,130 | $44,292 | $55,079 | $60,108 |
| Non-Current Assets | |||||
| PPE Net | 23 | 29 | 34 | 40 | 42 |
| Investments And Advances | 236 | 236 | 0 | 0 | -3 |
| Intangibles | 1 | 2 | 3 | 4 | 5 |
| Other Non-Current Assets | 153 | 230 | 307 | 83 | 166 |
| TOTAL | $413 | $497 | $343 | $127 | $210 |
| Total Assets | $20,988 | $24,627 | $44,635 | $55,206 | $60,318 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,166 | 1,800 | 13,488 | 13,382 | 10,606 |
| Accounts payable and accrued liabilities | 12,007 | 11,000 | 6,751 | 8,719 | 12,346 |
| Other current liabilities | 281 | 88 | 439 | 2,189 | 145 |
| TOTAL | $19,604 | $13,115 | $20,978 | $24,359 | $23,240 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,350 | 24,799 | 24,540 | 24,477 | 27,187 |
| TOTAL | $19,350 | $24,799 | $24,540 | $24,477 | $27,187 |
| Total Liabilities | $38,953 | $37,914 | $45,517 | $48,835 | $50,427 |
| Shareholders' Equity | |||||
| Common Shares | 65,189 | 63,932 | 63,850 | 63,701 | 63,620 |
| Retained earnings | -330,987 | -321,067 | -309,094 | -299,385 | -297,499 |
| Other shareholders' equity | 57 | 57 | -179 | -179 | -179 |
| TOTAL | $-17,965 | $-13,287 | $-882 | $6,371 | $9,890 |
| Total Liabilities And Equity | $20,988 | $24,627 | $44,635 | $55,206 | $60,318 |